Ascendis Pharma A (ASND) Deferred Taxes (2014 - 2017)

Ascendis Pharma A has disclosed Deferred Taxes across 4 years of filings, most recently posting $1.2 million for Q4 2017.

• Deferred Taxes for Q4 2017 came in at $1.2 million, up 51.49% year-over-year; the trailing twelve-month figure through Dec 2017 was $1.2 million (up 51.49% YoY), and the FY2017 annual result was $1.2 million, up 51.49% from the prior year.
• Deferred Taxes came in at $1.2 million for Q4 2017 at Ascendis Pharma A, up from $798995.9 in the prior quarter.
• In the past five years, Deferred Taxes ranged from a high of $1.2 million in Q4 2017 to a low of $798995.9 in Q4 2016.
• The 4-year median for Deferred Taxes is $945628.6 (2014), against an average of $975163.5.
• Across the five-year window, Deferred Taxes retreated 16.14% in 2015 and surged 51.49% in 2017, its largest moves.
• Ascendis Pharma A's Deferred Taxes stood at $1.0 million in 2014, then declined by 16.14% to $862644.3 in 2015, then declined by 7.38% to $798995.9 in 2016, then soared by 51.49% to $1.2 million in 2017.
• The last three Deferred Taxes figures came in at $1.2 million (Q4 2017), $798995.9 (Q4 2016), and $862644.3 (Q4 2015), per Business Quant data.